Skip to main content

Table 1 Baseline characteristics, mean ± SD or n (%)

From: Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

  ARMP
(n = 71)
Placebo
(n = 70)
Age (years) 55.6 ± 8.9 55.6 ± 9.3
Age groups
 < 65 years 61 (85.9%) 56 (80.0%)
 ≥ 65 years 10 (14.1%) 14 (20.0%)
Sex
 Males 42 (59.2%) 37 (52.9%)
 Females 29 (40.8%) 33 (47.1%)
Smoking
 Yes 17 (23.9%) 15 (21.4%)
 No 54 (76.1%) 55 (78.6%)
Weight (kg) 80.6 ± 12.6 80.7 ± 12.1
Height (cm) 165.5 ± 8.9 166.1 ± 8.0
BMI (kg/m2) 29.4 ± 3.6 29.2 ± 3.5
Waist circumference (cm) 100.8 ± 9.3 100.3 ± 8.7
SBP (mmHg) 130.6 ± 10.5 131.4 ± 10.6
DBP (mmHg) 80.7 ± 8.1 81.6 ± 8.0
Pulse rate (beats/min) 65.3 ± 9.5 68.3 ± 10.5
Ongoing-lipid lowering treatment
 Yes 41 (57.8%) 41 (58.6%)
 No 30 (42.2%) 29 (41.4%)
Tot-C (mg/dL) 224.3 ± 44.7 218.4 ± 38.2
LDL-C (mg/dL) 132.9 ± 36.5 128.4 ± 28.6
NHDL-C (mg/dL) 173.6 ± 41.8 168.0 ± 36.3
HDL-C (mg/dL) 50.7 ± 11.9 50.4 ± 12.1
TG (mg/dL) 151.3 ± 82.5 159.6 ± 86.6
LDL score 6.6 ± 7.1 6.8 ± 8.2
HbA1c (%) 5.5 ± 0.4 5.5 ± 0.4
Glucose (mg/dL) 103.9 ± 14.5 105.7 ± 17.9
HOMA-IR 4.1 ± 3.2 4.2 ± 2.4
Insulin (μU/ml) 15.7 ± 11.6 16.3 ± 9.0
CRP-Hs (Mg/L) 1.85 ± 2.34 1.35 ± 1.01
Stratum (number of subject)
 Missing LDL score 2 1
 LDL score = 0 15 19
 LDL score > 0 54 50